Data supporting mitochondrial morphological changes by SPG13-associated HSPD1 mutants.

Area of Science:

• Cell Biology
• Genetics
• Neuroscience

Background:

• Spastic Paraplegia 13 (SPG13) is linked to mutations in the HSPD1 gene.
• Specific mutations, Val-98-to-Ile (V98I) and Gln-461-to-Glu (Q461E), are associated with SPG13.
• HSPD1 encodes a mitochondrial protein crucial for mitochondrial function.

Purpose of the Study:

• To investigate the impact of SPG13-associated HSPD1 mutations (V98I and Q461E) on mitochondrial morphology and function.
• To understand the cellular mechanisms underlying HSPD1-related leukodystrophies.

Main Methods:

• Transfection of Cos-7 cells with HSPD1 V98I and Q461E mutant genes.
• Mitochondrial morphology assessment.
• Mitochondrial membrane potential measurement using MitoTracker dye.

Main Results:

• Both V98I and Q461E mutants resulted in an increased number of mitochondria.
• Mutant HSPD1 proteins caused shorter mitochondrial lengths.
• A decrease in mitochondrial membrane potential was observed in cells expressing either mutant.

Conclusions:

• SPG13-associated HSPD1 mutations induce significant alterations in mitochondrial morphology.
• These mutations lead to impaired mitochondrial function, evidenced by decreased membrane potential.
• The findings suggest a role for HSPD1 mutations in aberrant mitochondrial dynamics contributing to HLD and SPG13 pathogenesis.